Silenced SNHG1 Inhibited Epithelial-Mesenchymal Transition and Inflammatory Response of ARPE-19 Cells Induced by High Glucose

References

• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3
   PubMed Web of Science ®Google Scholar
• Thomas AA, Biswas S, Feng B, Chen S, Gonder J, Chakrabarti S. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia. 2019;62(3):517–530.
   PubMed Web of Science ®Google Scholar
• Liu Y, Song Y, Tao L, et al. Prevalence of diabetic retinopathy among 13473 patients with diabetes mellitus in China: a cross-sectional epidemiological survey in six provinces. BMJ Open. 2017;7(1):e013199. doi:10.1136/bmjopen-2016-013199
   PubMed Web of Science ®Google Scholar
• Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004;45(8):2760–2766. doi:10.1167/iovs.03-1392
   PubMed Web of Science ®Google Scholar
• Nawaz IM, Rezzola S, Cancarini A, et al. Human vitreous in proliferative diabetic retinopathy: characterization and translational implications. Prog Retin Eye Res. 2019;72:100756.
   PubMed Web of Science ®Google Scholar
• Machemer R, van Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978;85(2):181–191. doi:10.1016/S0002-9394(14)75946-X
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890. doi:10.1016/j.cell.2009.11.007
   PubMed Web of Science ®Google Scholar
• Zhou M, Geathers JS, Grillo SL, et al. Role of epithelial-mesenchymal transition in retinal pigment epithelium dysfunction. Front Cell Dev Biol. 2020;8:501. doi:10.3389/fcell.2020.00501
   PubMed Web of Science ®Google Scholar
• Che D, Zhou T, Lan Y, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38(6):1815–1822. doi:10.3892/ijmm.2016.2768
   PubMed Web of Science ®Google Scholar
• You ZP, Chen SS, Yang ZY, et al. GEP100/ARF6 regulates VEGFR2 signaling to facilitate high-glucose-induced epithelial-mesenchymal transition and cell permeability in retinal pigment epithelial cells. Am J Physiol Cell Physiol. 2019;316(6):C782–C791. doi:10.1152/ajpcell.00312.2018
   PubMed Web of Science ®Google Scholar
• Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491–2509. doi:10.1007/s00018-016-2174-5
   PubMed Web of Science ®Google Scholar
• Donato L, Scimone C, Alibrandi S, et al. Transcriptome analyses of lncRNAs in A2E-stressed retinal epithelial cells unveil advanced links between metabolic impairments related to oxidative stress and retinitis pigmentosa. Antioxidants (Basel). 2020;9:undefined.
   Google Scholar
• Thin KZ, Tu JC, Raveendran S. Long non-coding SNHG1 in cancer. Clin Chim Acta. 2019;494:38–47. doi:10.1016/j.cca.2019.03.002
   PubMed Web of Science ®Google Scholar
• Li Z, Lu Q, Zhu D, Han Y, Zhou X, Ren T. lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497. Biochem Biophys Res Commun. 2018;506(3):632–640. doi:10.1016/j.bbrc.2018.10.086
   PubMed Web of Science ®Google Scholar
• Xu M, Chen X, Lin K, et al. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p. Mol Cancer. 2018;17(1):141. doi:10.1186/s12943-018-0894-x
   PubMed Web of Science ®Google Scholar
• Guo W, Huang J, Lei P, Guo L, Li X. LncRNA SNHG1 promoted HGC-27 cell growth and migration via the miR-140/ADAM10 axis. Int J Biol Macromol. 2019;122:817–823. doi:10.1016/j.ijbiomac.2018.10.214
   PubMed Web of Science ®Google Scholar
• Liu ZQ, He WF, Wu YJ, et al. LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis. BMC Gastroenterol. 2020;20(1):156. doi:10.1186/s12876-020-01272-5
   PubMed Web of Science ®Google Scholar
• Bai J, Xu J, Zhao J, Zhang R. lncRNA SNHG1 cooperated with miR-497/miR-195-5p to modify epithelial-mesenchymal transition underlying colorectal cancer exacerbation. J Cell Physiol. 2020;235(2):1453–1468. doi:10.1002/jcp.29065
   PubMed Web of Science ®Google Scholar
• Bharti K, Nguyen MT, Skuntz S, Bertuzzi S, Arnheiter H. The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye. Pigment Cell Res. 2006;19(5):380–394. doi:10.1111/j.1600-0749.2006.00318.x
   PubMedGoogle Scholar
• Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis [published correction appears in J Cell Biol 2000 Apr 3; 149(1): following236]. J Cell Biol. 2000;148(4):779–790. doi:10.1083/jcb.148.4.779
   PubMed Web of Science ®Google Scholar
• Luo R, Li L, Hu YX, Xiao F. LncRNA H19 inhibits high glucose-induced inflammatory responses of human retinal epithelial cells by targeting miR-19b to increase SIRT1 expression [published online ahead of print, 2020 Oct 6]. Kaohsiung J Med Sci. 2020;37(2):101–110. doi:10.1002/kjm2.12302
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz J, Bernardes R, Lobo C. Blood-retinal barrier. Eur J Ophthalmol. 2011;21(Suppl 6):S3–S9. doi:10.5301/EJO.2010.6049
   PubMed Web of Science ®Google Scholar
• Lu Y, Xi J, Zhang Y, et al. SNHG1 inhibits ox-LDL-induced inflammatory response and apoptosis of HUVECs via up-regulating GNAI2 and PCBP1. Front Pharmacol. 2020;11:703. doi:10.3389/fphar.2020.00703
   PubMed Web of Science ®Google Scholar
• Lakkaraju A, Umapathy A, Tan LX, et al. The cell biology of the retinal pigment epithelium [published online ahead of print, 2020 Feb 24]. Prog Retin Eye Res. 2020;100846.
   PubMed Web of Science ®Google Scholar
• Yao Y, Guan M, Zhao XQ, Huang YF. Hypoxia and high glucose concentration on human retinitis pigmentosa in vitro culture. Chin J Med. 2003;83:1989–1992.
   Google Scholar
• Runkle EA, Antonetti DA. The blood-retinal barrier: structure and functional significance. Methods Mol Biol. 2011;686:133–148.
   PubMedGoogle Scholar
• Campbell HK, Maiers JL, DeMali KA. Interplay between tight junctions & adherens junctions. Exp Cell Res. 2017;358(1):39–44. doi:10.1016/j.yexcr.2017.03.061
   PubMed Web of Science ®Google Scholar
• Zou XL, Wang GF, Li DD, et al. Protection of tight junction between RPE cells with tissue factor targeting peptide. Int J Ophthalmol. 2018;11(10):1594–1599. doi:10.18240/ijo.2018.10.04
   PubMed Web of Science ®Google Scholar
• Zhao S, Wang Y, Luo M, Cui W, Zhou X, Miao L. Long noncoding RNA small nucleolar RNA host gene 1 (SNHG1) promotes renal cell carcinoma progression and metastasis by negatively regulating miR-137. Med Sci Monit. 2018;24:3824–3831. doi:10.12659/MSM.910866
   PubMed Web of Science ®Google Scholar
• Fresta CG, Caruso G, Fidilio A, et al. Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via P2X7 receptor. Int J Mol Sci. 2020;21(23):9305. doi:10.3390/ijms21239305
   PubMed Web of Science ®Google Scholar
• Anchi P, Swamy V, Godugu C. Nimbolide exerts protective effects in complete Freund’s adjuvant induced inflammatory arthritis via abrogation of STAT-3/NF-κB/Notch-1 signaling. Life Sci. 2021;266:118911. doi:10.1016/j.lfs.2020.118911
   PubMed Web of Science ®Google Scholar
• Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol. 2002;86(4):363–365. doi:10.1136/bjo.86.4.363
   PubMed Web of Science ®Google Scholar
• Rübsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol Sci. 2018;19(4):942. doi:10.3390/ijms19040942
   PubMed Web of Science ®Google Scholar
• Forrester JV, Kuffova L, Delibegovic M. The role of inflammation in diabetic retinopathy. Front Immunol. 2020;11:583687. doi:10.3389/fimmu.2020.583687
   PubMed Web of Science ®Google Scholar
• Samuels IS, Bell BA, Pereira A, Saxon J, Peachey NS. Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes. J Neurophysiol. 2015;113(4):1085–1099. doi:10.1152/jn.00761.2014
   PubMed Web of Science ®Google Scholar
• Shirasawa M, Sonoda S, Terasaki H, et al. TNF-α disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium. Exp Eye Res. 2013;110:59–69. doi:10.1016/j.exer.2013.02.012
   PubMed Web of Science ®Google Scholar
• Kuppner MC, McKillop-Smith S, Forrester JV. TGF-beta and IL-1 beta act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology. 1995;84(2):265–271.
   PubMed Web of Science ®Google Scholar
• Elner VM, Scales W, Elner SG, Danforth J, Kunkel SL, Strieter RM. Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells. Exp Eye Res. 1992;54(3):361–368. doi:10.1016/0014-4835(92)90048-W
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim YS, Kim JH, et al. Activation of ERK1/2-mTORC1-NOX4 mediates TGF-β1-induced epithelial-mesenchymal transition and fibrosis in retinal pigment epithelial cells. Biochem Biophys Res Commun. 2020;529(3):747–752. doi:10.1016/j.bbrc.2020.06.034
   PubMed Web of Science ®Google Scholar
• Pastor JC, de la Rúa ER, Martín F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 2002;21(1):127–144. doi:10.1016/S1350-9462(01)00023-4
   PubMed Web of Science ®Google Scholar
• Simó R, Villarroel M, Corraliza L, Hernández C, Garcia-Ramírez M. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier–implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol. 2010;2010:190724. doi:10.1155/2010/190724
   PubMedGoogle Scholar
• Hiscott P, Gray R, Grierson I, Gregor Z. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol. 1994;78(3):219–222. doi:10.1136/bjo.78.3.219
   PubMed Web of Science ®Google Scholar
• Saika S, Yamanaka O, Okada Y, et al. TGF beta in fibroproliferative diseases in the eye. Front Biosci (Schol Ed). 2009;1(1):376–390. doi:10.2741/s32
   PubMedGoogle Scholar
• Scimone C, Alibrandi S, Scalinci SZ, et al. Expression of pro-angiogenic markers is enhanced by blue light in human RPE cells. Antioxidants (Basel). 2020;9(11):1154. doi:10.3390/antiox9111154
   PubMedGoogle Scholar
• Donato L, Scimone C, Alibrandi S, et al. Possible A2E mutagenic effects on RPE mitochondrial DNA from innovative RNA-seq bioinformatics pipeline. Antioxidants (Basel). 2020;9(11):1158. doi:10.3390/antiox9111158
   PubMedGoogle Scholar
• Mesquida M, Drawnel F, Lait PJ, et al. Modelling macular edema: the effect of IL-6 and IL-6R blockade on human blood-retinal barrier integrity in vitro. Transl Vis Sci Technol. 2019;8(5):32. doi:10.1167/tvst.8.5.32
   PubMed Web of Science ®Google Scholar
• Jo DH, Yun JH, Cho CS, Kim JH, Kim JH, Cho CH. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy. Glia. 2019;67(2):321–331. doi:10.1002/glia.23542
   PubMed Web of Science ®Google Scholar